Insider · CIK 0001789894
Andrew Scott Blank
Files at BCDA (BioCardia, Inc.). First filing Apr 25, 2025, latest Sep 23, 2025.
Andrew Scott Blank files SEC Form 4 as director at BCDA (BioCardia, Inc.). Since Apr 25, 2025, Andrew Scott Blank has reported 3 open-market buys worth $760k and 0 open-market sells worth $0, the latest filed on Sep 23, 2025.
A track record needs three past buys with six months of prices behind them; Andrew Scott Blank has 0, so none is measured yet.
The newest scored trade: bought $360k of BCDA on Sep 19, 2025, filed Sep 23, 2025, scored 78 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BCDA: BioCardia, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 78Notable | BioCardia, Inc. | $360k 288,000 shares | +83% | 0% from low-63% from high | |
| 60Notable | BioCardia, Inc. | $150k 72,289 shares | +26% | +11% from low-38% from high | |
| 71Notable | BioCardia, Inc. | $250k 131,233 shares | +97% | +6% from low-40% from high |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | BCDA BioCardia, Inc. | AGrant or award Stock Option (right to buy)derivative | +12,000 | $0.00 | $0 | 15,313 | Dec 10, 2025 |
| Sep 19, 2025 | BCDA BioCardia, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +288,000 | $1.25 | $360k | 634,023 | Sep 23, 2025 |
| Sep 19, 2025 | BCDA BioCardia, Inc. | POpen-market purchase Warrant (right to buy)derivativeindirect: See Footnote | +288,000 | - | - | 602,522 | Sep 23, 2025 |
| Jun 30, 2025 | BCDA BioCardia, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +72,289 | $2.08 | $150k | 346,023 | Jul 2, 2025 |
| Jun 30, 2025 | BCDA BioCardia, Inc. | POpen-market purchase Warrant (right to buy)derivativeindirect: See Footnote | +72,289 | - | - | 314,522 | Jul 2, 2025 |
| Apr 23, 2025 | BCDA BioCardia, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +131,233 | $1.91 | $250k | 265,957 | Apr 25, 2025 |
| Apr 23, 2025 | BCDA BioCardia, Inc. | POpen-market purchase Warrant (right to buy)derivativeindirect: See Footnote | +131,233 | - | - | 242,233 | Apr 25, 2025 |
| Oct 11, 2024 | BCDA BioCardia, Inc. | AGrant or award Stock Option (right to buy)derivative | +829 | $0.00 | $0 | 3,313 | Oct 16, 2024 |
Questions about Andrew Scott Blank
Answered from the filings on this page, as of the latest one.
Is Andrew Scott Blank buying or selling?
Not in the last 12 months. Andrew Scott Blank's latest open-market trade on SEC Form 4 was bought $360k of BCDA on Sep 19, 2025.
How did Andrew Scott Blank's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrew Scott Blank has 0.
Where does Andrew Scott Blank file Form 4?
Andrew Scott Blank has filed Form 4 at BCDA (BioCardia, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.